Clinical trials
Shock, Septic trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
83 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2011 | 1 |
| 2012 | 4 |
| 2013 | 7 |
| 2014 | 5 |
| 2015 | 4 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 6 |
| 2019 | 8 |
| 2020 | 6 |
| 2021 | 4 |
| 2022 | 4 |
| 2023 | 8 |
| 2024 | 4 |
| 2025 | 7 |
| 2026 | 10 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 31 |
| Unknown status | 31 |
| Not yet recruiting | 10 |
| Recruiting | 8 |
| Enrolling by invitation | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Southeast University, China | 12 |
| First Affiliated Hospital of Wannan Medical College | 8 |
| Peking Union Medical College Hospital | 7 |
| Zhujiang Hospital | 5 |
| Northern Jiangsu People's Hospital | 4 |
| Xiangya Hospital of Central South University | 4 |
| Zhongda Hospital | 4 |
| Children's Hospital of Fudan University | 2 |
| Jinhua Central Hospital | 2 |
| Zhongnan Hospital | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shock, Septic | 83 |
| Sepsis | 34 |
| Acute Kidney Injury | 7 |
| Critical Illness | 4 |
| Multiple Organ Failure | 3 |
| Cognitive Dysfunction | 2 |
| Hemophilia B | 2 |
| Hypotension | 2 |
| Infections | 2 |
| Systemic Inflammatory Response Syndrome | 2 |
Trials
Showing 1 to 25 of 83. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.